Page last updated: 2024-10-17

choline and Bone Cancer

choline has been researched along with Bone Cancer in 90 studies

Research Excerpts

ExcerptRelevanceReference
"Twenty-six patients with painful, bony metastases were recruited into a randomized, double-blind, single dose, two-treatment, three-part crossover study of choline magnesium trisalicylate (CMT) and placebo."9.07The efficacy of choline magnesium trisalicylate (CMT) in the management of metastatic bone pain: a pilot study. ( Johnson, JR; Miller, AJ, 1994)
"The present study was conducted to compare the diagnostic accuracy between carbon-11 choline (11C-choline) positron emission tomography (PET)/computed tomography (CT) and conventional imaging for the staging of bone and soft tissue sarcomas."7.73Staging performance of carbon-11 choline positron emission tomography/computed tomography in patients with bone and soft tissue sarcoma: comparison with conventional imaging. ( Arai, Y; Kakizoe, T; Kawai, A; Maeda, T; Moriyama, N; Seki, K; Tateishi, U; Terauchi, T; Yamaguchi, U, 2006)
"Viable bone metastases and osteoblastic change induced by the treatment effect were identified in 53 (94."5.62Assessment of the viability and treatment response of bone metastases in patients with metastatic castration-resistant prostate cancer using choline PET/CT. ( Hanasaki, T; Kanematsu, A; Kawanaka, Y; Kitajima, K; Komoto, H; Nagasawa, S; Shimatani, K; Taguchi, M; Yamada, Y; Yamakado, K; Yamamoto, S, 2021)
"Twenty-six patients with painful, bony metastases were recruited into a randomized, double-blind, single dose, two-treatment, three-part crossover study of choline magnesium trisalicylate (CMT) and placebo."5.07The efficacy of choline magnesium trisalicylate (CMT) in the management of metastatic bone pain: a pilot study. ( Johnson, JR; Miller, AJ, 1994)
"The present study was conducted to compare the diagnostic accuracy between carbon-11 choline (11C-choline) positron emission tomography (PET)/computed tomography (CT) and conventional imaging for the staging of bone and soft tissue sarcomas."3.73Staging performance of carbon-11 choline positron emission tomography/computed tomography in patients with bone and soft tissue sarcoma: comparison with conventional imaging. ( Arai, Y; Kakizoe, T; Kawai, A; Maeda, T; Moriyama, N; Seki, K; Tateishi, U; Terauchi, T; Yamaguchi, U, 2006)
"Musculoskeletal tumors comprise a multitude of tumor entities with different grades of malignancy, biological behavior, and therapeutic options."2.50PET tracers in musculoskeletal disease beyond FDG. ( Benz, MR; Buck, AK; Herrmann, K; Pomykala, KL; Wieder, HA, 2014)
"In patients with a high risk of distant metastases and suitable for systemic salvage therapy, a positive lesion must be obviously visualized with one of the currently available imaging techniques."2.49The dilemma of localizing disease relapse after radical treatment for prostate cancer: which is the value of the actual imaging techniques? ( Borghesi, M; Brunocilla, E; Castellucci, P; Ceci, F; Fanti, S; Gacci, M; Martorana, G; Nanni, C; Schiavina, R; Vagnoni, V, 2013)
"Viable bone metastases and osteoblastic change induced by the treatment effect were identified in 53 (94."1.62Assessment of the viability and treatment response of bone metastases in patients with metastatic castration-resistant prostate cancer using choline PET/CT. ( Hanasaki, T; Kanematsu, A; Kawanaka, Y; Kitajima, K; Komoto, H; Nagasawa, S; Shimatani, K; Taguchi, M; Yamada, Y; Yamakado, K; Yamamoto, S, 2021)
"Forty-nine consecutive prostate cancer patients diagnosed with oligometastatic recurrence on Ch-PET have been prospectively treated."1.51Outcomes after a first and/or second salvage treatment in patients with oligometastatic prostate cancer recurrence detected by (18-F) choline PET-CT. ( Ahtamon, A; Bilbao, P; Cacicedo, J; Casquero Ocio, F; Fernandez, I; Garcia-Olaverri, J; Gomez-Iturriaga, A; Llarena, R; Ortiz de Zarate, R; Ost, P; Rodeño, E, 2019)
"A 76-year-old man with metastatic prostate cancer and back pain was referred for palliative radiotherapy."1.48Prostate Cancer Lytic Bone Metastases Imaged With 18F-Fluorocholine PET/CT. ( Alabed, YZ, 2018)
"56 patients diagnosed with prostate cancer underwent 99mTc-methylendiphosphonates bone scintigraphy (99mTc-MDP-BS) and fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) or fluorine-18-fluorocholine PET/CT (18F-FCH-PET/CT) within six weeks."1.48Detection of the Prostate Cancer Bone Metastases: Is It Feasible to Compare 18F-fluorocholine PET/CT, 18F-fluorodeoxyglucose PET/CT and 99mTc-methyl Diphosphonate Bone Scintigraphy? ( Cholewinski, W; Czepczynski, R; Pietrzak, AK; Wierzchoslawska, E, 2018)
"Twenty Japanese prostate cancer patients underwent 11C-choline and FDG PET/CT before (n=5) or after (n=15) treatment."1.48Diagnostic Performance of 11C-choline PET/CT and FDG PET/CT in Prostate Cancer. ( Fujiwara, M; Fukushima, K; Hashimoto, T; Kamikonya, N; Kanematsu, A; Kitajima, K; Kobayashi, K; Nakanishi, Y; Nojima, M; Odawara, S; Suzuki, T; Yamada, Y; Yamakado, K; Yamamoto, S, 2018)
"An 84-year-old man with a history of prostate cancer, treated with radiotherapy, presented with an increase in PSA levels."1.46Internal Auditory Canal Tumor as an Incidental Finding on a Choline PET/CT Scan in a Prostate Cancer Patient. ( Efthymiadou, R; Malamitsi, J; Pipikos, T; Prassopoulos, V; Vlachou, F, 2017)
"F-choline PET/CT was performed for suspected prostate cancer relapse in a 67-year-old man with hip pain and a rapid rise in prostate-specific antigen values (1."1.4318F-Choline PET/CT-Positive Lytic Bone Lesions in Prostate Cancer and Accidental Myeloma Detection. ( Castellani, M; Cortelezzi, A; Florimonte, L; Longari, V; Orunesu, E, 2016)
"In two cases history of a second malignancy (lung cancer and cutaneous basocellular carcinoma) was known (diagnosed 12 and 6 years after PCa, respectively)."1.43Detection of a second malignancy in prostate cancer patients by using [(18)F]Choline PET/CT: a case series. ( Boni, R; Castellucci, P; Coraggio, G; Erba, PA; Galeandro, M; Lazzeri, E; Paiar, F; Pasqualetti, F; Perri, M; Roncali, M; Sollini, M; Versari, A, 2016)
"multi-parametric MRI in the prostate cancer relapse."1.42(11)C-choline PET/CT and multiparametric MRI in patients with biochemical relapse of prostate cancer. ( Cozar, M; Escobar, M; Garcia, JR; Moragas, M; Romera, N; Soler, M, 2015)
"In the initial staging of high-risk prostate cancer, metastatic nodes could be detected if there are more than 5 mm, especially those localized outside the lymphadenectomy area."1.40[Focus: Prostate cancer and PET-choline]. ( Brenot-Rossi, I, 2014)
"Fifty-five patients with biopsy-proven prostate cancer or suspected recurrent prostate cancer were examined with simultaneous [18F] choline Positron emission tomography (PET)/MRI at 3 T."1.40Quantitative evaluation of bone metastases from prostate cancer with simultaneous [18F] choline PET/MRI: combined SUV and ADC analysis. ( Heusch, P; Lauenstein, TC; Lipponer, C; Nagarajah, J; Nensa, F; Pöppel, TD; Rübben, H; Schlosser, TW; Wetter, A, 2014)
"Choline was only found in six benign lesions."1.39Study of single voxel 1H MR spectroscopy of bone tumors: differentiation of benign from malignant tumors. ( Cheng, K; Cheng, X; Ding, Y; Liang, W; Vanel, D; Zhang, J, 2013)
"Patients with prostate cancer with prostate specific antigen (PSA) levels between 20 and 99 ng/mL and/or Gleason score 8-10 tumours, planned for treatment with curative intent based on routine staging with a negative or inconclusive bone scan, were further investigated with a (18)F-fluorocholine and a (18)F-fluoride PET/CT."1.38Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer. ( Ahlgren, G; Almquist, H; Bratt, O; Kjölhede, H; Liedberg, F; Lyttkens, K; Ohlsson, T, 2012)
"Choline SNRs were different for malignant and benign lesions (11."1.34Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy. ( Barker, PB; Bluemke, DA; Eng, J; Fayad, LM; Jacobs, MA; Kulesza, P; Weber, KL, 2007)
"Choline was detected in 18 of 19 patients with malignant tumors and in three of 17 patients with benign lesions."1.32Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results. ( Chien, SH; Hsieh, TJ; Li, CW; Liu, GC; Tsai, KB; Wang, CK, 2004)

Research

Studies (90)

TimeframeStudies, this research(%)All Research%
pre-19901 (1.11)18.7374
1990's1 (1.11)18.2507
2000's22 (24.44)29.6817
2010's60 (66.67)24.3611
2020's6 (6.67)2.80

Authors

AuthorsStudies
Faudemer, J1
Meriaux, E1
Tillou, X1
Aide, N1
Filippi, L1
Basile, P1
Schillaci, O2
Bagni, O1
de Leiris, N2
Leenhardt, J1
Boussat, B1
Montemagno, C1
Seiller, A1
Phan Sy, O1
Roux, J1
Laramas, M2
Verry, C1
Iriart, C1
Fiard, G1
Long, JA1
Descotes, JL1
Vuillez, JP1
Riou, L2
Djaileb, L2
Ruggeri, V1
Amrane, K1
Le Pennec, R1
Tissot, V1
Schick, U1
Abgral, R1
Kitajima, K3
Yamamoto, S3
Kawanaka, Y1
Komoto, H1
Shimatani, K1
Hanasaki, T1
Taguchi, M2
Nagasawa, S1
Yamada, Y3
Kanematsu, A3
Yamakado, K3
Haroon, A1
Syed, R1
Endozo, R1
Allie, R1
Freeman, A1
Emberton, M1
Bomanji, J1
Lapa, P1
Saraiva, T1
Silva, R1
Marques, M1
Costa, G1
Lima, JP1
García Vicente, AM1
Soriano Castrejón, Á1
Alvarez Cabellos, R1
Sanchez Gil, B1
Mohedano Mohedano, N1
Incerti, E1
Gangemi, V1
Mapelli, P1
Deantoni, CL1
Giovacchini, G3
Fallanca, F2
Fodor, A1
Ciarmiello, A1
Baldari, S1
Gianolli, L3
Di Muzio, N1
Picchio, M3
Malamitsi, J1
Efthymiadou, R1
Pipikos, T1
Vlachou, F1
Prassopoulos, V1
Bongiovanni, A1
Recine, F1
Celli, M1
Marcantognini, G1
Foca, F1
Liverani, C1
Fausti, V1
De Vita, A1
Miserocchi, G1
Mercatali, L1
Amadori, D1
Ibrahim, T1
Dyrberg, E1
Larsen, EL1
Hendel, HW1
Thomsen, HS1
Alabed, YZ1
Pietrzak, AK1
Czepczynski, R1
Wierzchoslawska, E1
Cholewinski, W1
Vija Racaru, L1
Sinigaglia, M1
Kanoun, S1
Ben Bouallègue, F1
Tal, I1
Brillouet, S1
Bauriaud-Mallet, M1
Zerdoud, S1
Dierickx, L1
Vallot, D1
Caselles, O1
Gabiache, E1
Pascal, P1
Courbon, F1
Odawara, S1
Kobayashi, K1
Fujiwara, M1
Kamikonya, N1
Fukushima, K1
Nakanishi, Y2
Hashimoto, T2
Suzuki, T2
Nojima, M2
Guo, Y1
Wang, L1
Hu, J1
Feng, D1
Xu, L1
Oshima, K1
Go, S1
Trump, T1
Luchey, AM1
Hogg, J1
Mattes, MD1
Mujukian, A1
Kay, M1
Scimeca, M1
Urbano, N1
Bonfiglio, R1
Mapelli, SN1
Catapano, CV1
Carbone, GM1
Ciuffa, S1
Tavolozza, M1
Mauriello, A1
Bonanno, E1
Gomez-Iturriaga, A1
Casquero Ocio, F1
Ost, P1
Fernandez, I1
Rodeño, E1
Llarena, R1
Garcia-Olaverri, J1
Ortiz de Zarate, R1
Cacicedo, J1
Ahtamon, A1
Bilbao, P1
Zhou, J1
Gou, Z1
Wu, R1
Yuan, Y1
Yu, G1
Zhao, Y1
Cuccurullo, V2
Cascini, GL1
Tamburrini, O2
Rotondo, A2
Mansi, L2
Schiavina, R4
Ceci, F2
Borghesi, M1
Brunocilla, E2
Vagnoni, V1
Gacci, M1
Castellucci, P4
Nanni, C2
Martorana, G3
Fanti, S4
Wondergem, M1
van der Zant, FM1
van der Ploeg, T1
Knol, RJ1
Wetter, A2
Lipponer, C2
Nensa, F2
Heusch, P2
Rübben, H2
Altenbernd, JC1
Schlosser, T1
Bockisch, A1
Pöppel, T1
Lauenstein, T1
Nagarajah, J2
Brenot-Rossi, I1
Treglia, G1
Ceriani, L1
Barizzi, J1
Paone, G1
Giovanella, L1
Schlosser, TW1
Pöppel, TD1
Lauenstein, TC1
Wieder, HA1
Pomykala, KL1
Benz, MR1
Buck, AK1
Herrmann, K2
De Bari, B1
Alongi, F1
Lestrade, L1
Giammarile, F1
Shen, G1
Deng, H1
Hu, S1
Jia, Z1
Garcia, JR3
Jorcano, S1
Soler, M4
Linero, D1
Moragas, M4
Riera, E3
Miralbell, R1
Lomeña, F3
Balogova, S3
Zakoun, JB1
Michaud, L1
Khalil, A1
Tassart, M1
Esteso, A1
Kerrou, K4
Huchet, V3
Carette, MF1
Lotz, JP1
Talbot, JN4
Goldstein, J1
Even-Sapir, E1
Ben-Haim, S1
Saad, A1
Spieler, B1
Davidson, T1
Berger, R1
Weiss, I1
Appel, S1
Lawrence, YR1
Symon, Z1
Romera, N1
Cozar, M1
Escobar, M1
Tabrizipour, AI1
Dunne, M1
Evangelista, L1
Cimitan, M1
Zattoni, F2
Guttilla, A1
Saladini, G1
Koo, PJ1
David Crawford, E1
Graziani, T1
Chondrogiannis, S1
Bonfiglioli, R1
Costa, S1
Virgolini, IJ1
Rubello, D2
Colletti, PM1
Maines, F1
Caffo, O1
Donner, D1
Sperduti, I1
Bria, E1
Veccia, A1
Chierichetti, F1
Tortora, G1
Galligioni, E1
Florimonte, L1
Orunesu, E1
Castellani, M1
Longari, V1
Cortelezzi, A1
Zanoni, L1
Pultrone, C1
Lodi, F1
Malizia, C1
Ferrari, M1
Rigatti, P1
Fonti, C1
Doyle-Lindrud, S1
Azad, GK1
Cook, GJ1
Schwenck, J1
Rempp, H1
Reischl, G1
Kruck, S1
Stenzl, A1
Nikolaou, K1
Pfannenberg, C1
la Fougère, C1
Sollini, M1
Pasqualetti, F1
Perri, M1
Coraggio, G1
Roncali, M1
Boni, R1
Lazzeri, E1
Galeandro, M1
Paiar, F1
Versari, A1
Erba, PA1
Scalzi, P1
Baiocco, C1
Genovese, S1
Trevisan, A1
Sirotova, Z1
Poti, C1
Parker, WP1
Evans, JD1
Stish, BJ1
Park, SS1
Olivier, K1
Choo, R1
Nathan, MA1
Welch, BT1
Karnes, RJ1
Mynderse, LA1
Pisansky, TM1
Kwon, ED1
Lowe, VJ1
Davis, BJ1
Tuncel, M1
Souvatzoglou, M1
Stollfuss, J1
Schuster, T1
Weirich, G1
Wester, HJ1
Schwaiger, M1
Krause, BJ1
Luboldt, W1
Küfer, R1
Blumstein, N1
Toussaint, TL1
Kluge, A1
Seemann, MD1
Luboldt, HJ1
Samanes Gajate, AM1
Messa, C3
Fazio, F2
Lindholm, P1
Seppänen, M1
Minn, H1
Kwee, SA1
Coel, MN1
Ly, BH1
Lim, J1
Lecouvet, FE1
Vande Berg, BC1
Malghem, J1
Omoumi, P1
Simoni, P1
Fuccio, C1
Santi, I1
Allegri, V1
Pettinato, V1
Boschi, S1
Al-Nahhas, A1
Doganay, S1
Altinok, T1
Alkan, A1
Kahraman, B1
Karakas, HM1
Muacevic, A1
Kufeld, M1
Rist, C1
Wowra, B1
Stief, C1
Staehler, M1
Cascini, G1
Rossi, A1
Langsteger, W5
Beheshti, M4
Paycha, F1
Egrot, C1
Janetschek, G1
Loidl, W2
Nataf, V1
Pascal, O1
Cussenot, O2
Tian, M3
Zhang, H3
Endo, K3
Zengerling, F1
Schrader, AJ1
Schrader, M1
Jentzmik, F1
Spinapolice, EG1
Crivellaro, C1
Zhang, J1
Cheng, K1
Ding, Y2
Liang, W1
Vanel, D1
Cheng, X1
Subhawong, TK1
Wang, X1
Durand, DJ1
Jacobs, MA3
Carrino, JA1
Machado, AJ1
Fayad, LM4
Kjölhede, H1
Ahlgren, G1
Almquist, H1
Liedberg, F1
Lyttkens, K1
Ohlsson, T1
Bratt, O1
Poulsen, MH1
Bouchelouche, K1
Høilund-Carlsen, PF1
Petersen, H1
Gerke, O1
Steffansen, SI1
Marcussen, N1
Svolgaard, N1
Vach, W1
Geertsen, U1
Walter, S1
Valls, E2
Garcia, G1
Bassa, P1
Landoni, C1
Matarrese, M1
De Cobelli, F1
Maschio, AD1
Oriuchi, N2
Higuchi, T2
Watanabe, H1
Aoki, J1
Tanada, S1
Wang, CK1
Li, CW1
Hsieh, TJ1
Chien, SH1
Liu, GC1
Tsai, KB1
Bluemke, DA3
McCarthy, EF1
Weber, KL2
Barker, PB3
Heinisch, M1
Fogelman, I1
Yoshida, S1
Nakagomi, K1
Goto, S1
Futatsubashi, M1
Torizuka, T1
Tateishi, U1
Yamaguchi, U1
Maeda, T1
Seki, K1
Terauchi, T1
Kawai, A1
Arai, Y1
Moriyama, N1
Kakizoe, T1
Gutman, F2
Aflalo-Hazan, V1
Montravers, F2
Grahek, D2
Vali, R2
Eng, J1
Kulesza, P1
Kerrouche, N1
Gattegno, B1
Thibault, P1
Sah, PL1
Sharma, R1
Kandpal, H1
Seith, A1
Rastogi, S1
Bandhu, S1
Jagannathan, NR1
Waldenberger, P1
Fitz, F1
Nader, M1
Broinger, G1
Stoiber, F1
Foglman, I1
Johnson, JR1
Miller, AJ1
Singh, AT1
Radeff, JM1
Kunnel, JG1
Stern, PH1
Potter, M1

Clinical Trials (8)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Two Bed SPECT/CT Versus Planar Bone Scintigraphy in Detection of Osseous Metastases in Patients With Genitourinary Malignancies[NCT05597215]70 participants (Anticipated)Observational2022-12-31Not yet recruiting
All-in-One Prostate Cancer Staging With MRI[NCT06071195]400 participants (Anticipated)Observational2021-12-22Recruiting
PRISMA-PET - Primary Staging of Prostate Cancer: A Randomized Controlled Trial Comparing 18F-PSMA-1007 PET/CT to Conventional Imaging[NCT05123300]448 participants (Anticipated)Interventional2021-10-04Recruiting
Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) PET/CT Utilizing the High Resolution Digital Philips Vereos Scanner, in Patients With Biochemical Recurrence After Radical Prostatectomy[NCT04234399]22 participants (Actual)Observational2020-03-01Active, not recruiting
A Multi-center, Open-label, Single Arm Phase III Clinical Trial for the Diagnostic Efficacy Assessment and Safety Evaluation by [18F]Florastamin PET/CT Imaging Examination in Patients With Suspected Recurrent or Metastatic Prostate Cancer[NCT05936658]Phase 389 participants (Anticipated)Interventional2023-05-08Recruiting
Evaluation of [18F] Fluorocholine PET/CT for Detection of Regional Lymph Node Metastases From Prostate Cancer[NCT00670527]205 participants (Anticipated)Interventional2008-01-31Recruiting
Multi-paramEtric Imaging to Assess Treatment REsponse After Stereotactic Radiosurgery of Brain Metastases[NCT04626206]12 participants (Anticipated)Observational2020-12-31Not yet recruiting
F-choline PET in Early Response Assessment for Castration Resistant Prostatic Cancer Treated by Abiraterone Acetate or Enzalutamide[NCT01981707]Phase 2/Phase 312 participants (Actual)Interventional2013-12-31Terminated (stopped due to enrollment default)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

19 reviews available for choline and Bone Cancer

ArticleYear
Osteoblastic bone metastases from neuroendocrine tumor (NET) of unknown origin detected by 18fluorocholine PET/CT and its comparison with 68gallium-DOTATOC PET/CT: Case report and review of the literature.
    Medicine, 2017, Volume: 96, Issue:46

    Topics: Aged; Bone Neoplasms; Choline; Humans; Ilium; Male; Neuroendocrine Tumors; Organometallic Compounds;

2017
Diagnostic performance of choline PET/CT for the detection of bone metastasis in prostate cancer: A systematic review and meta-analysis.
    PloS one, 2018, Volume: 13, Issue:9

    Topics: Bone Neoplasms; Choline; Humans; Male; Positron Emission Tomography Computed Tomography; Prostatic N

2018
Comparison of PSMA-PET/CT, choline-PET/CT, NaF-PET/CT, MRI, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a systematic review and meta-analysis.
    Skeletal radiology, 2019, Volume: 48, Issue:12

    Topics: Bone Neoplasms; Choline; Gallium Isotopes; Gallium Radioisotopes; Humans; Magnetic Resonance Imaging

2019
Bone metastases radiopharmaceuticals: an overview.
    Current radiopharmaceuticals, 2013, Volume: 6, Issue:1

    Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Choline; Dihydroxyphenylalanine; Diphosphonates; Fluorine Rad

2013
The dilemma of localizing disease relapse after radical treatment for prostate cancer: which is the value of the actual imaging techniques?
    Current radiopharmaceuticals, 2013, Jun-06, Volume: 6, Issue:2

    Topics: Bone Neoplasms; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutanes; Fluorine Radioisotope

2013
A literature review of 18F-fluoride PET/CT and 18F-choline or 11C-choline PET/CT for detection of bone metastases in patients with prostate cancer.
    Nuclear medicine communications, 2013, Volume: 34, Issue:10

    Topics: Bone Neoplasms; Carbon Radioisotopes; Choline; Fluorides; Fluorine Radioisotopes; Humans; Male; Mult

2013
PET tracers in musculoskeletal disease beyond FDG.
    Seminars in musculoskeletal radiology, 2014, Volume: 18, Issue:2

    Topics: Amino Acids; Bone Diseases; Bone Neoplasms; Carbon Radioisotopes; Choline; Dideoxynucleosides; Fluor

2014
Choline-PET in prostate cancer management: the point of view of the radiation oncologist.
    Critical reviews in oncology/hematology, 2014, Volume: 91, Issue:3

    Topics: Biomarkers, Tumor; Bone Neoplasms; Choline; Gamma Rays; Humans; Male; Neoplasm Recurrence, Local; Po

2014
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.
    Skeletal radiology, 2014, Volume: 43, Issue:11

    Topics: Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Observer Vari

2014
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.
    Skeletal radiology, 2014, Volume: 43, Issue:11

    Topics: Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Observer Vari

2014
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.
    Skeletal radiology, 2014, Volume: 43, Issue:11

    Topics: Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Observer Vari

2014
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.
    Skeletal radiology, 2014, Volume: 43, Issue:11

    Topics: Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Observer Vari

2014
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.
    Skeletal radiology, 2014, Volume: 43, Issue:11

    Topics: Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Observer Vari

2014
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.
    Skeletal radiology, 2014, Volume: 43, Issue:11

    Topics: Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Observer Vari

2014
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.
    Skeletal radiology, 2014, Volume: 43, Issue:11

    Topics: Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Observer Vari

2014
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.
    Skeletal radiology, 2014, Volume: 43, Issue:11

    Topics: Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Observer Vari

2014
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.
    Skeletal radiology, 2014, Volume: 43, Issue:11

    Topics: Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Observer Vari

2014
¹⁸F-NaF PET/CT and ¹¹C-Choline PET/CT for the initial detection of metastatic disease in prostate cancer: overview and potential utilization.
    Oncology (Williston Park, N.Y.), 2014, Volume: 28, Issue:12

    Topics: Bone Neoplasms; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Male; Multimodal Imag

2014
New Positron-Emission Tomography/Computed Tomography Imaging for Bone Metastases
.
    Clinical journal of oncology nursing, 2016, Volume: 20, Issue:2

    Topics: Bone Neoplasms; Choline; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasm

2016
Multi-technique imaging of bone metastases: spotlight on PET-CT.
    Clinical radiology, 2016, Volume: 71, Issue:7

    Topics: Bone Neoplasms; Choline; Contrast Media; Evidence-Based Medicine; Fluorodeoxyglucose F18; Humans; Im

2016
Pathophysiological premises to radiotracers for bone metastases.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2011, Volume: 55, Issue:4

    Topics: Bone and Bones; Bone Neoplasms; Choline; Dihydroxyphenylalanine; Diphosphonates; Humans; Iodine Radi

2011
[Diagnostic relevance of choline-PET / CT in patients with prostate cancer].
    Aktuelle Urologie, 2012, Volume: 43, Issue:1

    Topics: Bone Neoplasms; Carbon Radioisotopes; Choline; Disease Progression; Fluorine Radioisotopes; Humans;

2012
Proton MR spectroscopy in metabolic assessment of musculoskeletal lesions.
    AJR. American journal of roentgenology, 2012, Volume: 198, Issue:1

    Topics: Algorithms; Biomarkers, Tumor; Bone Neoplasms; Choline; Contrast Media; Humans; Image Interpretation

2012
The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast.
    Seminars in nuclear medicine, 2006, Volume: 36, Issue:1

    Topics: Bone Neoplasms; Breast Neoplasms; Choline; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeo

2006
[Clinical usefulness of positron emission tomography in prostate cancer].
    Presse medicale (Paris, France : 1983), 2007, Volume: 36, Issue:12 Pt 2

    Topics: Bone Neoplasms; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recu

2007
Molecular characterization of musculoskeletal tumors by proton MR spectroscopy.
    Seminars in musculoskeletal radiology, 2007, Volume: 11, Issue:3

    Topics: Bone Neoplasms; Choline; Creatine; Humans; Lipid Metabolism; Magnetic Resonance Spectroscopy; Proton

2007
Immunoglobulin-producing tumors and myeloma proteins of mice.
    Physiological reviews, 1972, Volume: 52, Issue:3

    Topics: Amino Acid Sequence; Amyloidosis; Animals; Antigens, Neoplasm; Antigens, Viral; Bence Jones Protein;

1972

Trials

6 trials available for choline and Bone Cancer

ArticleYear
Spectrum of metastatic and nonmetastatic skeletal findings with dual-phase 18F-FECH PET/CT in patients with biochemical relapse of prostate cancer.
    Nuclear medicine communications, 2017, Volume: 38, Issue:5

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Humans; Male; Middle Aged; Positron Emission Tomog

2017
(18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:9

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutan

2016
(18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:9

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutan

2016
(18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:9

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutan

2016
(18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:9

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutan

2016
(18)F-Choline PET/CT imaging of RECIST measurable lesions in hormone refractory prostate cancer.
    Annals of nuclear medicine, 2009, Volume: 23, Issue:6

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Case-Control Studies; Choline; Hormones; Humans; Male; Midd

2009
Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors.
    European journal of nuclear medicine and molecular imaging, 2004, Volume: 31, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Brain Neoplasms; Carbon Radioisotopes; C

2004
Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT: a comparative study.
    European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:10

    Topics: Adult; Bone Neoplasms; Choline; Fluorine Radioisotopes; Humans; Male; Positron-Emission Tomography;

2008
The efficacy of choline magnesium trisalicylate (CMT) in the management of metastatic bone pain: a pilot study.
    Palliative medicine, 1994, Volume: 8, Issue:2

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Bone Neoplasms; Choline; Dose-Resp

1994

Other Studies

65 other studies available for choline and Bone Cancer

ArticleYear
Normalization of Liver Physiological Uptake as a Response Marker to Treatment in Prostate Cancer Liver Metastases Appearing as Photopenic on Baseline 18F-Fluorocholine PET/CT.
    Clinical nuclear medicine, 2023, Feb-01, Volume: 48, Issue:2

    Topics: Bone Neoplasms; Choline; Humans; Liver Neoplasms; Male; Middle Aged; Positron Emission Tomography Co

2023
The Relationship Between Total Lesion Activity on
    Cancer biotherapy & radiopharmaceuticals, 2020, Volume: 35, Issue:6

    Topics: Aged; Aged, 80 and over; Alpha Particles; Bone and Bones; Bone Neoplasms; Choline; Feasibility Studi

2020
Does whole-body bone SPECT/CT provide additional diagnostic information over [18F]-FCH PET/CT for the detection of bone metastases in the setting of prostate cancer biochemical recurrence?
    Cancer imaging : the official publication of the International Cancer Imaging Society, 2020, Aug-12, Volume: 20, Issue:1

    Topics: Aged; Bone Neoplasms; Choline; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomo

2020
Aggressive Bone Metastatic Prostate Cancer With Periosteal Reaction in 18F-Choline PET/CT.
    Clinical nuclear medicine, 2021, Feb-01, Volume: 46, Issue:2

    Topics: Aged; Bone Neoplasms; Choline; Humans; Male; Osteogenesis; Positron Emission Tomography Computed Tom

2021
Incidental Findings of a Vestibular Schwannoma on 18F-Choline PET/CT.
    Clinical nuclear medicine, 2021, Feb-01, Volume: 46, Issue:2

    Topics: Aged; Bone Neoplasms; Brain; Choline; Humans; Incidental Findings; Magnetic Resonance Imaging; Male;

2021
Assessment of the viability and treatment response of bone metastases in patients with metastatic castration-resistant prostate cancer using choline PET/CT.
    Medicine, 2021, Jun-11, Volume: 100, Issue:23

    Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Choline; Humans; Male; Middle Aged; Neoplasm Metasta

2021
[Superiority of 18F-FNa PET/CT for Detecting Bone Metastases in Comparison with Other Diagnostic Imaging Modalities].
    Acta medica portuguesa, 2017, Jan-31, Volume: 30, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Choline; Female; Fluorodeoxyglucose F18;

2017
Response Assessment of 223Ra Treatment: Should a Fluorocholine PET/CT Be Performed?
    Clinical nuclear medicine, 2017, Volume: 42, Issue:10

    Topics: Aged; Bone Neoplasms; Choline; Humans; Male; Positron Emission Tomography Computed Tomography; Prost

2017
11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients.
    Current radiopharmaceuticals, 2017, Nov-10, Volume: 10, Issue:3

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis

2017
Internal Auditory Canal Tumor as an Incidental Finding on a Choline PET/CT Scan in a Prostate Cancer Patient.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:12

    Topics: Aged, 80 and over; Bone Neoplasms; Choline; Humans; Incidental Findings; Male; Neuroma, Acoustic; Po

2017
Diagnostic bone imaging in patients with prostate cancer: patient experience and acceptance of NaF-PET/CT, choline-PET/CT, whole-body MRI, and bone SPECT/CT.
    Acta radiologica (Stockholm, Sweden : 1987), 2018, Volume: 59, Issue:9

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Humans; Magnetic Resonance Imaging; Male; Middle A

2018
Prostate Cancer Lytic Bone Metastases Imaged With 18F-Fluorocholine PET/CT.
    Clinical nuclear medicine, 2018, Volume: 43, Issue:3

    Topics: Aged; Bone Neoplasms; Choline; Humans; Male; Neoplasm Staging; Palliative Care; Positron Emission To

2018
Detection of the Prostate Cancer Bone Metastases: Is It Feasible to Compare 18F-fluorocholine PET/CT, 18F-fluorodeoxyglucose PET/CT and 99mTc-methyl Diphosphonate Bone Scintigraphy?
    Urology journal, 2018, 09-26, Volume: 15, Issue:5

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hu

2018
Fluorine-18-fluorocholine PET/CT parameters predictive for hematological toxicity to radium-223 therapy in castrate-resistant prostate cancer patients with bone metastases: a pilot study.
    Nuclear medicine communications, 2018, Volume: 39, Issue:7

    Topics: Aged; Aged, 80 and over; Blood; Bone Neoplasms; Choline; Humans; Male; Middle Aged; Pilot Projects;

2018
Diagnostic Performance of 11C-choline PET/CT and FDG PET/CT in Prostate Cancer.
    Acta medica Okayama, 2018, Volume: 72, Issue:3

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Huma

2018
[The Usefulness of 11C-Choline PET/CT for Detecting Metastasis and Treatment Monitoring of Renal Cell Carcinoma : Report of Two Cases].
    Hinyokika kiyo. Acta urologica Japonica, 2018, Volume: 64, Issue:8

    Topics: Aged; Bone Neoplasms; Carbon Radioisotopes; Carcinoma, Renal Cell; Choline; Humans; Kidney Neoplasms

2018
Intramedullary Reactive Fibrosis as Mimic of Prostate Cancer Bone Metastasis on 11C-Choline Positron Emission and Computed Tomography.
    Practical radiation oncology, 2019, Volume: 9, Issue:1

    Topics: Bone and Bones; Bone Neoplasms; Carbon Radioisotopes; Choline; Fibrosis; Humans; Male; Middle Aged;

2019
Indeterminate single bone lesion on multimodality imaging of prostate cancer.
    BMJ case reports, 2019, Jan-07, Volume: 12, Issue:1

    Topics: Adenocarcinoma; Aged; Bone Neoplasms; Choline; Diagnosis, Differential; Diphosphonates; Disease Prog

2019
Prostate Osteoblast-Like Cells: A Reliable Prognostic Marker of Bone Metastasis in Prostate Cancer Patients.
    Contrast media & molecular imaging, 2018, Volume: 2018

    Topics: Bone Neoplasms; Calcification, Physiologic; Calcinosis; Cell Differentiation; Cell Shape; Choline; E

2018
Outcomes after a first and/or second salvage treatment in patients with oligometastatic prostate cancer recurrence detected by (18-F) choline PET-CT.
    European journal of cancer care, 2019, Volume: 28, Issue:5

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Bone Neoplasms; Carcinoma; Choline; Fluori

2019
Evaluation of the PET component of simultaneous [(18)F]choline PET/MRI in prostate cancer: comparison with [(18)F]choline PET/CT.
    European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:1

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Humans; Lymphatic Metastasis; Magnetic Resonance I

2014
[Focus: Prostate cancer and PET-choline].
    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2014, Volume: 24, Issue:1

    Topics: Bone Neoplasms; Choline; Fluorine Radioisotopes; Humans; Male; Positron-Emission Tomography; Prostat

2014
Colorectal carcinoma with bone metastases detected by 18F-choline PET/CT.
    Clinical nuclear medicine, 2014, Volume: 39, Issue:3

    Topics: Aged; Biopsy; Bone Neoplasms; Choline; Colorectal Neoplasms; Humans; Male; Multimodal Imaging; Posit

2014
Quantitative evaluation of bone metastases from prostate cancer with simultaneous [18F] choline PET/MRI: combined SUV and ADC analysis.
    Annals of nuclear medicine, 2014, Volume: 28, Issue:5

    Topics: Aged; Aged, 80 and over; Biological Transport; Bone Neoplasms; Carbon Radioisotopes; Choline; Diffus

2014
11C-Choline PET/CT in the primary diagnosis of prostate cancer: impact on treatment planning.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2015, Volume: 59, Issue:3

    Topics: Aged; Biopsy; Bone Neoplasms; Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis; Male; Mid

2015
Whole-body 18F-fluorocholine (FCH) PET/CT and MRI of the spine for monitoring patients with castration-resistant prostate cancer metastatic to bone: a pilot study.
    Clinical nuclear medicine, 2014, Volume: 39, Issue:11

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Fluorine Radioisotopes; Humans; Magnetic Resonance

2014
Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
    American journal of clinical oncology, 2017, Volume: 40, Issue:3

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Brachytherapy; Carbon Radioisotopes; Choline; Humans; Lymph

2017
(11)C-choline PET/CT and multiparametric MRI in patients with biochemical relapse of prostate cancer.
    Actas urologicas espanolas, 2015, Volume: 39, Issue:4

    Topics: Adenocarcinoma; Bone Neoplasms; Carbon Radioisotopes; Choline; Combined Modality Therapy; Humans; Ly

2015
The role of 18F-flourocholine PET/CT in biochemically relapsed prostate cancer: a case of osteolytic prostate metastasis.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:5

    Topics: Adenocarcinoma; Bone Neoplasms; Choline; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emi

2015
Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A
    Scandinavian journal of urology, 2015, Volume: 49, Issue:5

    Topics: Abdomen; Aged; Aged, 80 and over; Bone Neoplasms; Choline; Fluorine Radioisotopes; Humans; Lymph Nod

2015
11C-choline PET/CT identifies osteoblastic and osteolytic lesions in patients with metastatic prostate cancer.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:5

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; M

2015
Serial 18F-choline-PET imaging in patients receiving enzalutamide for metastatic castration-resistant prostate cancer: response assessment and imaging biomarkers.
    Future oncology (London, England), 2016, Volume: 12, Issue:3

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Bone Neoplasms; Choli

2016
18F-Choline PET/CT-Positive Lytic Bone Lesions in Prostate Cancer and Accidental Myeloma Detection.
    Clinical nuclear medicine, 2016, Volume: 41, Issue:5

    Topics: Aged; Bone Neoplasms; Carcinoma; Choline; Humans; Incidental Findings; Male; Multiple Myeloma; Posit

2016
Comparison of
    European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:1

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Edetic Acid; Gallium Isotopes; Gallium Radioisotop

2017
Detection of a second malignancy in prostate cancer patients by using [(18)F]Choline PET/CT: a case series.
    Cancer imaging : the official publication of the International Cancer Imaging Society, 2016, Aug-31, Volume: 16, Issue:1

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Fluorodeoxyglucose F18; Humans; Kallikreins; Lung

2016
Evaluation of bone metastases by 18F-choline PET/CT in a patient with castration-resistant prostate cancer treated with radium-223.
    Urologia, 2017, Feb-03, Volume: 84, Issue:1

    Topics: Adenocarcinoma; Aged; Bone Neoplasms; Choline; Fluorine Radioisotopes; Humans; Male; Positron Emissi

2017
Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed Tomography.
    International journal of radiation oncology, biology, physics, 2017, 03-01, Volume: 97, Issue:3

    Topics: Aged; Bone Neoplasms; Carbon Radioisotopes; Choline; Humans; Lymphatic Metastasis; Male; Middle Aged

2017
[(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer.
    Nuclear medicine and biology, 2008, Volume: 35, Issue:6

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; N

2008
Prostate carcinoma: diffusion-weighted imaging as potential alternative to conventional MR and 11C-choline PET/CT for detection of bone metastases.
    Radiology, 2008, Volume: 249, Issue:3

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance

2008
Increased C-11 choline uptake in pagetic bone in a patient with coexisting skeletal metastases from prostate cancer.
    Clinical nuclear medicine, 2008, Volume: 33, Issue:11

    Topics: Aged; Bone Neoplasms; Carbon Radioisotopes; Cell Proliferation; Choline; Diagnosis, Differential; Fe

2008
The role of PET/CT and current challenges in prostate cancer management.
    Nuclear medicine communications, 2009, Volume: 30, Issue:5

    Topics: Acetates; Bone Neoplasms; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Male; Posit

2009
Diffusion-weighted MR imaging: adjunct or alternative to T1-weighted MR imaging for prostate carcinoma bone metastases?
    Radiology, 2009, Volume: 252, Issue:2

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Diffusion Magnetic Resonance

2009
Role of 11C-choline PET/CT in the restaging of prostate cancer patients showing a single lesion on bone scintigraphy.
    Annals of nuclear medicine, 2010, Volume: 24, Issue:6

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; N

2010
The role of MRS in the differentiation of benign and malignant soft tissue and bone tumors.
    European journal of radiology, 2011, Volume: 79, Issue:2

    Topics: Adolescent; Adult; Aged; Bone Neoplasms; Choline; Contrast Media; Diagnosis, Differential; Female; G

2011
Safety and feasibility of image-guided robotic radiosurgery for patients with limited bone metastases of prostate cancer.
    Urologic oncology, 2013, Volume: 31, Issue:4

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Feasibility Studies; Fluorine Radioisotopes; Follo

2013
Fluorocholine (18F) and sodium fluoride (18F) PET/CT in the detection of prostate cancer: prospective comparison of diagnostic performance determined by masked reading.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2011, Volume: 55, Issue:4

    Topics: Aged; Aged, 80 and over; Bone Neoplasms; Choline; Fluorine Radioisotopes; Humans; Male; Middle Aged;

2011
Comparison of cell proliferation, protein, and glucose metabolism in musculoskeletal tumors in a PET study.
    Journal of biomedicine & biotechnology, 2011, Volume: 2011

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Area Under Curve; Bone Neoplasms; Carbon Radioisotopes;

2011
[11C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy.
    European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:1

    Topics: Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Carbon Radioisotopes; Choline; Humans; Male

2012
Study of single voxel 1H MR spectroscopy of bone tumors: differentiation of benign from malignant tumors.
    European journal of radiology, 2013, Volume: 82, Issue:12

    Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Bone Neoplasms; Child; Choline; Diagnosis, Differential;

2013
Choline PET/CT compared with bone scintigraphy in the detection of bone metastases in prostate cancer patients.
    European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:5

    Topics: Bone and Bones; Bone Neoplasms; Choline; Humans; Male; Multimodal Imaging; Positron-Emission Tomogra

2012
Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.
    BJU international, 2012, Volume: 110, Issue:10

    Topics: Aged; Bone Neoplasms; Choline; Fluorides; Fluorine Radioisotopes; Humans; Lymphatic Metastasis; Male

2012
[18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
    BJU international, 2012, Volume: 110, Issue:11

    Topics: Aged; Bone Neoplasms; Choline; Fluorine Radioisotopes; Humans; Lymph Node Excision; Lymph Nodes; Lym

2012
[Metabolic and osteogenic pattern of prostate cancer bone metastases].
    Revista espanola de medicina nuclear e imagen molecular, 2013, Volume: 32, Issue:1

    Topics: Aged; Bone Neoplasms; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Male; Multimoda

2013
Bone metastases from prostate cancer: 18F-fluoride PET/CT in a patient with discordant bone scintigraphy and 11C-choline PET/CT.
    Clinical nuclear medicine, 2013, Volume: 38, Issue:2

    Topics: Bone Neoplasms; Carbon Radioisotopes; Choline; Fluorides; Fluorine Radioisotopes; Humans; Male; Mult

2013
Positive [11C]choline and negative [18F]FDG with positron emission tomography in recurrence of prostate cancer.
    AJR. American journal of roentgenology, 2002, Volume: 179, Issue:2

    Topics: Adenocarcinoma; Aged; Bone Neoplasms; Choline; False Negative Reactions; Fluorodeoxyglucose F18; Hum

2002
11C-choline PET for the detection of bone and soft tissue tumours in comparison with FDG PET.
    Nuclear medicine communications, 2003, Volume: 24, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biological Transport; Bone Diseases; Bone Neoplasms; Car

2003
Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results.
    Radiology, 2004, Volume: 232, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Neoplasms; Choline; Diagnosis, Diff

2004
Musculoskeletal tumors: use of proton MR spectroscopic imaging for characterization.
    Journal of magnetic resonance imaging : JMRI, 2006, Volume: 23, Issue:1

    Topics: Bone Neoplasms; Choline; Diagnosis, Differential; Humans; In Vitro Techniques; Magnetic Resonance Sp

2006
C-choline positron emission tomography in bladder cancer: report of four cases.
    International journal of urology : official journal of the Japanese Urological Association, 2006, Volume: 13, Issue:6

    Topics: Aged; Bone Neoplasms; Carbon Isotopes; Choline; Female; Humans; Male; Middle Aged; Positron-Emission

2006
Staging performance of carbon-11 choline positron emission tomography/computed tomography in patients with bone and soft tissue sarcoma: comparison with conventional imaging.
    Cancer science, 2006, Volume: 97, Issue:10

    Topics: Adolescent; Adult; Aged; Bone Neoplasms; Carbon Radioisotopes; Choline; Female; Humans; Male; Middle

2006
18F-choline PET/CT for initial staging of advanced prostate cancer.
    AJR. American journal of roentgenology, 2006, Volume: 187, Issue:6

    Topics: Aged; Bone Neoplasms; Choline; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Prostat

2006
[18F]fluorocholine PET/CT in the assessment of bone metastases in prostate cancer.
    European journal of nuclear medicine and molecular imaging, 2007, Volume: 34, Issue:8

    Topics: Bone Neoplasms; Choline; Hormones; Humans; Male; Neoplasm Metastasis; Positron-Emission Tomography;

2007
Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy.
    AJR. American journal of roentgenology, 2007, Volume: 188, Issue:6

    Topics: Adolescent; Adult; Biomarkers; Bone Neoplasms; Choline; Female; Humans; Magnetic Resonance Spectrosc

2007
In vivo proton spectroscopy of giant cell tumor of the bone.
    AJR. American journal of roentgenology, 2008, Volume: 190, Issue:2

    Topics: Adolescent; Adult; Biomarkers, Tumor; Bone Neoplasms; Carcinoma, Giant Cell; Child; Choline; Female;

2008
Phosphatidylcholine-specific phospholipase C inhibitor, tricyclodecan-9-yl xanthogenate (D609), increases phospholipase D-mediated phosphatidylcholine hydrolysis in UMR-106 osteoblastic osteosarcoma cells.
    Biochimica et biophysica acta, 2000, Sep-27, Volume: 1487, Issue:2-3

    Topics: Antineoplastic Agents; Bone Neoplasms; Bridged-Ring Compounds; Choline; Down-Regulation; Drug Synerg

2000